FR2928549B1 - Utilisation d'un extrait de l'orchidee brassocattleya marcella koss en tant qu'actif pour prevenir ou retarder l'apparition des signes du vieillissement cutane - Google Patents

Utilisation d'un extrait de l'orchidee brassocattleya marcella koss en tant qu'actif pour prevenir ou retarder l'apparition des signes du vieillissement cutane

Info

Publication number
FR2928549B1
FR2928549B1 FR0851640A FR0851640A FR2928549B1 FR 2928549 B1 FR2928549 B1 FR 2928549B1 FR 0851640 A FR0851640 A FR 0851640A FR 0851640 A FR0851640 A FR 0851640A FR 2928549 B1 FR2928549 B1 FR 2928549B1
Authority
FR
France
Prior art keywords
orchidee
signs
delay
extract
appearance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0851640A
Other languages
English (en)
French (fr)
Other versions
FR2928549A1 (fr
Inventor
Jean Hubert Cauchard
Jean Christophe Archambault
Krystell Lazou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LVMH Recherche GIE
Original Assignee
LVMH Recherche GIE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LVMH Recherche GIE filed Critical LVMH Recherche GIE
Priority to FR0851640A priority Critical patent/FR2928549B1/fr
Priority to DE102009012271A priority patent/DE102009012271A1/de
Priority to JP2009058436A priority patent/JP5642354B2/ja
Priority to US12/382,250 priority patent/US8293287B2/en
Priority to KR1020090020825A priority patent/KR20090098705A/ko
Publication of FR2928549A1 publication Critical patent/FR2928549A1/fr
Application granted granted Critical
Publication of FR2928549B1 publication Critical patent/FR2928549B1/fr
Priority to KR1020160092484A priority patent/KR20160091300A/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
FR0851640A 2008-03-13 2008-03-13 Utilisation d'un extrait de l'orchidee brassocattleya marcella koss en tant qu'actif pour prevenir ou retarder l'apparition des signes du vieillissement cutane Active FR2928549B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0851640A FR2928549B1 (fr) 2008-03-13 2008-03-13 Utilisation d'un extrait de l'orchidee brassocattleya marcella koss en tant qu'actif pour prevenir ou retarder l'apparition des signes du vieillissement cutane
DE102009012271A DE102009012271A1 (de) 2008-03-13 2009-03-11 Verwendung eines Brassocattleya marcella Koss Orchideenextraktes als einen Wirkstoff zur Vermeidung oder Verzögerung des Auftretens von Anzeichen von Hautalterung
JP2009058436A JP5642354B2 (ja) 2008-03-13 2009-03-11 皮膚老化の兆候の出現を予防または遅延させる活性薬剤としてのブラソカトレア・マーセラ・コス（Ｂｒａｓｓｏｃａｔｔｌｅｙａ ｍａｒｃｅｌｌａ Ｋｏｓｓ）ラン抽出物の使用
US12/382,250 US8293287B2 (en) 2008-03-13 2009-03-11 Use of a Brassocattleya marcella Koss orchid extract as an active agent to prevent or delay the appearance of signs of cutaneous aging
KR1020090020825A KR20090098705A (ko) 2008-03-13 2009-03-11 피부 노화 징후의 출현을 방지 또는 지연시키기 위한 활성제로서의 브라소카틀레야 마르셀라 코스 난초 추출물의용도
KR1020160092484A KR20160091300A (ko) 2008-03-13 2016-07-21 피부 노화 징후의 출현을 방지 또는 지연시키기 위한 활성제로서의 브라소카틀레야 마르셀라 코스 난초 추출물의 용도

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0851640A FR2928549B1 (fr) 2008-03-13 2008-03-13 Utilisation d'un extrait de l'orchidee brassocattleya marcella koss en tant qu'actif pour prevenir ou retarder l'apparition des signes du vieillissement cutane

Publications (2)

Publication Number Publication Date
FR2928549A1 FR2928549A1 (fr) 2009-09-18
FR2928549B1 true FR2928549B1 (fr) 2013-07-26

Family

ID=40010626

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0851640A Active FR2928549B1 (fr) 2008-03-13 2008-03-13 Utilisation d'un extrait de l'orchidee brassocattleya marcella koss en tant qu'actif pour prevenir ou retarder l'apparition des signes du vieillissement cutane

Country Status (5)

Country Link
US (1) US8293287B2 (enExample)
JP (1) JP5642354B2 (enExample)
KR (2) KR20090098705A (enExample)
DE (1) DE102009012271A1 (enExample)
FR (1) FR2928549B1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2951376B1 (fr) * 2009-10-16 2016-07-15 Lvmh Rech Nouvelle utilisation d'un extrait de l'orchidee vanda coerulea
FR2964567B1 (fr) * 2010-09-14 2013-03-15 Lvmh Rech Extrait d'orchidee
CN106266587B (zh) * 2015-06-02 2019-11-29 青山兰花生物科技有限公司 兰花萃取物及其制备方法和应用
FR3039766B1 (fr) * 2015-08-03 2018-09-07 Lvmh Recherche Composition cosmetique exfoliante
TW201815408A (zh) * 2016-10-20 2018-05-01 蘭卉生物科技股份有限公司 蘭花葉子萃取物及其添加產品

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02279618A (ja) * 1989-04-20 1990-11-15 Ichimaru Pharcos Co Ltd ラン科植物抽出物含有化粧料
FR2784027B1 (fr) * 1998-10-05 2000-12-08 Serobiologiques Lab Sa Utilisation d'un extrait de boldo dans un produit cosmetique ou dermatologique et produit comportant un tel extrait
JP2002145730A (ja) * 2000-11-10 2002-05-22 Katakura Chikkarin Co Ltd 化粧料
JP2002205933A (ja) * 2001-01-05 2002-07-23 Ichimaru Pharcos Co Ltd ラン科植物抽出物含有化粧料組成物
JP2004067549A (ja) * 2002-08-02 2004-03-04 Kose Corp 皮膚外用剤
JP2004307352A (ja) * 2003-04-02 2004-11-04 Croda Japan Kk ボルジン誘導体を含有する化粧料または皮膚外用剤
DE502004002112D1 (de) * 2003-04-24 2007-01-04 Coty Bv Kosmetikum zur depigmentierung
FR2871058B1 (fr) * 2004-06-03 2006-09-22 Gunzburg Jean De Association a base d'extraits vegetaux et composition topique la contenant

Also Published As

Publication number Publication date
KR20160091300A (ko) 2016-08-02
JP5642354B2 (ja) 2014-12-17
JP2009221201A (ja) 2009-10-01
US20090258093A1 (en) 2009-10-15
KR20090098705A (ko) 2009-09-17
FR2928549A1 (fr) 2009-09-18
US8293287B2 (en) 2012-10-23
DE102009012271A1 (de) 2009-12-03

Similar Documents

Publication Publication Date Title
FR2920967B1 (fr) Utilisation de l'hydroxymethionine en tant qu'actif anti age
SMT201500176B (it) Composizioni e metodi per inibire l'espressione ditranstiretina
EP2714032A4 (en) NEW DIPHENYLMETHANE DERIVATIVES AS SGLT2 INHIBITORS
EP2906037A4 (en) COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE FLAVONOID AND FERULA ACID
EP2498772A4 (en) COMPOSITION AND METHOD FOR IMPROVED APPEARANCE OF THE SKIN
ZA201101818B (en) Modified release emulsions for application to skin or viginal mucosa
EP2391344A4 (en) COMPOSITION FOR NAIL AND SKIN TREATMENT
BRPI0916123A2 (pt) "composição de xampu concentrada"
EP2782583A4 (en) METHOD AND COMPOSITIONS FOR REDUCING AN ALCOHOL TOXICITY
EP2127646A4 (en) MEANS TO PREVENT OR PREVENT XEROSTOMY
EP2654745A4 (en) COMPOSITION FOR THE TREATMENT OF HAIR DRESSES
EP2155147A4 (en) ALOE PREPARATION FOR SKIN IMPROVEMENT
ZA201100653B (en) Topical composition for the treatment of ctinic keratosis
EP2591105A4 (en) METHOD AND COMPOSITIONS FOR SPECIFIC BETA CATENINE INHIBITION BY DOUBLE-STRENGTH RNA
EP2384250A4 (en) THE EFFICIENCY IMPROVING COMPOSITION
BRPI0914503A2 (pt) "composição de shampoo concentrado"
FR2933271B1 (fr) Compositions topiques pour la conservation du corps humain ou animal
FR2928549B1 (fr) Utilisation d'un extrait de l'orchidee brassocattleya marcella koss en tant qu'actif pour prevenir ou retarder l'apparition des signes du vieillissement cutane
FR2996136B1 (fr) Utilisation d'une association d'au moins un acide gras polyinsature et d'au moins un carotenoide pour ameliorer la qualite des ongles.
EP2486925A4 (en) Therapeutic agent for cerebral infarction
IT1393841B1 (it) Composizione farmaceutica o dermatologica o nutrizionale o cosmetica per combattere l'azione di immunosoppressione provocata sulla pelle da agenti aggressivi
EP2350642A4 (en) NA / K ATPASE EXPRESSION AS AN INDICATOR FOR THE TREATMENT OF CANCER
EP2623476A4 (en) USE OF CARBOXYMETHYLCHITOSANES AS ADDITIVES FOR AGGLOMERATION OF COMPOSITIONS
EP2444091A4 (en) USE OF TOOSENDANIN OR MELIA AZEDARACH EXTRACTS FOR THE PREVENTION OR TREATMENT OF DEMENTIA
EP3138850B8 (en) Compositions containing deoxycholic acid and 10% deionized water in ethanol, directed to the purification of deoxycholic acid

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10